Aalberts N.V. (LON:0NX1)

Verve Therapeutics Revenue

Aalberts had revenue of 1.56B EUR in the half year ending June 30, 2025, a decrease of -9.33%. This brings the company's revenue in the last twelve months to 3.09B, down -4.31% year-over-year. In the year 2024, Aalberts had annual revenue of 3.15B, down -5.28%.

• Revenue (ttm): 3.09B EUR
• Revenue Growth: -4.31%
• P/S Ratio: 1.00
• Revenue / Employee: 235.20K EUR
• Employees: 13,124
• Market Cap: 2.64B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.15B	-175.40M	-5.28%
Dec 31, 2023	3.32B	94.00M	2.91%
Dec 31, 2022	3.23B	250.90M	8.42%
Dec 31, 2021	2.98B	368.70M	14.12%
Dec 31, 2020	2.61B	-230.90M	-8.13%